# 3-Dimensional Conformal Radiation Therapy in Treating Patients With Bladder Cancer Who Have Undergone Transurethral Resection of the Bladder

> **NCT01124682** · PHASE1 · UNKNOWN · sponsor: **Institute of Cancer Research, United Kingdom** · enrollment: 60 (estimated)

## Conditions studied

- Bladder Cancer

## Interventions

- **PROCEDURE:** diagnostic cystoscopy
- **PROCEDURE:** diffusion-weighted magnetic resonance imaging
- **PROCEDURE:** implanted fiducial-based imaging
- **PROCEDURE:** quality-of-life assessment
- **RADIATION:** 3-dimensional conformal radiation therapy
- **RADIATION:** image-guided radiation therapy
- **RADIATION:** selective external radiation therapy

## Key facts

- **NCT ID:** NCT01124682
- **Lead sponsor:** Institute of Cancer Research, United Kingdom
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-05
- **Primary completion:** 2016-04
- **Final completion:** —
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2013-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01124682

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01124682, "3-Dimensional Conformal Radiation Therapy in Treating Patients With Bladder Cancer Who Have Undergone Transurethral Resection of the Bladder". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01124682. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*